Some California Stem Cell Board Members Bristle at IOM Recommendations
Some directors of the $3 billion California stem cell agency today sharply challenged recommendations by the Institute of Medicine(IOM) concerning conflicts of interest and the role of patient advocates on the governing board.
Much of the criticism came from the 10 patient advocate members on the board, whose roles would be significantly altered under …
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.